Access the full text.
Sign up today, get DeepDyve free for 14 days.
Exp Ther Med, 11
F. Schmidt (2008)
Meta-AnalysisOrganizational Research Methods, 11
L. Davies, H. Welch (2014)
Current thyroid cancer trends in the United States.JAMA otolaryngology-- head & neck surgery, 140 4
M. Rahman, A. Salajegheh, Robert Smith, A. Lam (2015)
Multiple proliferation-survival signalling pathways are simultaneously active in BRAF V600E mutated thyroid carcinomas.Experimental and molecular pathology, 99 3
F. Maia, P. Matos, B. Silva, Ana Pallone, E. Pavin, J. Vassallo, D. Zantut-Wittmann (2011)
Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid noduleHead & Neck Oncology, 3
Lancet, 384
Min Kim, J. Won, K. Jung, Ji-hoon Kim, Sun Cho, D. Park, Y. Park (2018)
Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma.Thyroid : official journal of the American Thyroid Association, 28 3
Lifang Jin, Changsong Xu, Xueqian Xie, Fan Li, Xiu-Hong Lv, L. Du (2017)
An Algorithm of Image Heterogeneity with Contrast-Enhanced Ultrasound in Differential Diagnosis of Solid Thyroid Nodules.Ultrasound in medicine & biology, 43 1
JAMA Oncol
Yi Zheng, Shang-Yan Xu, Huili Kang, W. Zhan (2018)
A Single-Center Retrospective Validation Study of the American College of Radiology Thyroid Imaging Reporting and Data SystemUltrasound Quarterly, 34
Tae Kim, Y. Park, J. Lim, H. Ahn, Eun-Kyung Lee, You Lee, Kyung Kim, S. Hahn, Y. Youn, K. Kim, B. Cho, D. Park (2012)
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancerCancer, 118
Gisele Oler, J. Cerutti (2009)
High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomasCancer, 115
Kaliszewski, Diakowska, Strutyńska-Karpińska, Wojtczak, Domosławski, Balcerzak (2017)
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Miribi Rho, Eun-Kyung Kim, H. Moon, J. Yoon, V. Park, Kyunghwa Han, J. Kwak (2017)
Clinical Parameter for Deciding the BRAFV600E Mutation Test in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Thyroid Nodules: US Features According to TIRADSUltrasound Quarterly, 33
Lucheng Zhu, Yun-Liang Ye, Wenhua Luo, M. Su, Hangping Wei, Xue-bang Zhang, Juan Wei, C. Zou (2013)
A Model to Discriminate Malignant from Benign Thyroid Nodules Using Artificial Neural NetworkPLoS ONE, 8
R. Siegel, K. Miller, A. Jemal (2017)
Cancer statistics, 2017CA: A Cancer Journal for Clinicians, 67
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
Sang Park, Bomyee Lee, Sangeun Lee, E. Choi, Eun-Bi Choi, Jisu Yoo, J. Jun, K. Choi (2015)
A qualitative study of women’s views on overdiagnosis and screening for thyroid cancer in KoreaBMC Cancer, 15
(2018)
Association between BRAF(V600E) mutation and theAmerican College of Radiology thyroid imaging, reporting and data system in solitary papillary thyroid carcinoma [published online ahead of print
O. Ozgursoy, D. Eisele, R. Tufano (2014)
The prognostic implications from molecular testing of thyroid cancer.Otolaryngologic clinics of North America, 47 4
P. Campanella, F. Ianni, C. Rota, S. Corsello, A. Pontecorvi (2014)
Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis.European journal of endocrinology, 170 5
(2009)
High Prevalence of BRAF Mutation in a Brazilian Cohort of PatientsWith Sporadic Papillary Thyroid Carcinomas Correlation With More Aggressive Phenotype and Decreased Expression of Iodide-Metabolizing Genes
Biyun Sun, Lin Lang, Xiangming Zhu, Feng Jiang, Yun Hong, Lianping He (2015)
Accuracy of contrast-enhanced ultrasound in the identification of thyroid nodules: a meta-analysis.International journal of clinical and experimental medicine, 8 8
F. Tessler, W. Middleton, E. Grant, J. Hoang, L. Berland, S. Teefey, J. Cronan, M. Beland, T. Desser, M. Frates, L. Hammers, U. Hamper, J. Langer, C. Reading, L. Scoutt, A. Stavros (2018)
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee.Journal of the American College of Radiology : JACR, 14 5
Rengyun Liu, J. Bishop, Guangwu Zhu, Zhang Tao, P. Ladenson, Mingzhao Xing (2017)
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer MortalityJAMA Oncology, 3
V. Mehta, Y. Nikiforov, R. Ferris (2012)
Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgeryHead & Neck, 35
B. Howitt, Yonghui Jia, L. Sholl, J. Barletta (2013)
Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma.Thyroid : official journal of the American Thyroid Association, 23 10
P. Miccoli (2014)
Application of Molecular Diagnostics to the Evaluation of the Surgical Approach to Thyroid CancerCurrent Genomics, 15
Yihao Liu, Lei Su, Haipeng Xiao (2017)
Review of Factors Related to the Thyroid Cancer EpidemicInternational Journal of Endocrinology, 2017
I. Sugitani, K. Toda, Keiko Yamada, N. Yamamoto, M. Ikenaga, Y. Fujimoto (2010)
Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and OutcomesWorld Journal of Surgery, 34
B. Haugen, E. Alexander, K. Bible, Gerard Doherty, S. Mandel, Y. Nikiforov, F. Pacini, G. Randolph, A. Sawka, M. Schlumberger, K. Schuff, S. Sherman, J. Sosa, D. Steward, R. Tuttle, L. Wartofsky (2009)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.Thyroid : official journal of the American Thyroid Association, 26 1
Mingzhao Xing, Ali Alzahrani, Kathryn Carson, D. Viola, R. Elisei, B. Bendlova, L. Yip, C. Mian, F. Vianello, R. Tuttle, E. Robenshtok, James Fagin, E. Puxeddu, L. Fugazzola, A. Czarniecka, B. Jarzab, Christine O’Neill, M. Sywak, Alfred Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Nakayama, R. Tufano, Sara Pai, M. Zeiger, William Westra, Douglas Clark, R. Clifton-Bligh, D. Sidransky, P. Ladenson, V. Sykorova (2013)
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.JAMA, 309 14
Fengsheng Li, Yunmei Wang, B. Bai, Shengli Wang, Shuguang Liu (2017)
Advantages of Routine Ultrasound Combined With Contrast-Enhanced Ultrasound in Diagnosing Papillary Thyroid CarcinomaUltrasound Quarterly, 33
Mingzhao Xing, B. Haugen, M. Schlumberger (2013)
Progress in molecular-based management of differentiated thyroid cancerThe Lancet, 381
(1955)
[Carcinoma].Die Medizinische, 6
Qiong Wu, Yan Wang, Yi Li, Bing Hu, Zhi He (2016)
Diagnostic value of contrast-enhanced ultrasound in solid thyroid nodules with and without enhancementEndocrine, 53
Objective The objective of this study was to analyze the association among the thyroid imaging reporting and data system (TI-RADS), quantitative parameters obtained from contrast-enhanced ultrasonography (CEUS), and BRAF V600E mutation status in patients with papillary thyroid microcarcinoma. Patients From November 2016 to June 2017, 54 patients who had undergone thyroid CEUS and BRAF V600E mutation analysis for papillary thyroid microcarcinoma were enrolled in our study. The patients were divided into 2 groups based on mutation status. Sex, age, pathology results, TI-RADS score, and quantitative CEUS parameters were compared between the 2 groups. Results There were 43 patients in the BRAF V600E–positive group and 11 patients in the BRAF V600E–negative group. Age and TI-RADS score were not associated with mutation status. The arrival time (17.2 ± 5.1 seconds) and time to peak enhancement (TTP) (26.5 ± 7.4 seconds) of the lesions in the BRAF V600E–positive group were longer than the arrival time (13.2 ± 3.1 seconds) and TTP (21.1 ± 4.4 seconds) of the lesions in the BRAF V600E–negative group. Basic intensity and peak intensity were not associated with mutation status. Conclusions There is an association between the arrival time and TTP of CEUS and BRAF V600E mutation status. They may help infer the BRAF V600E mutation status in papillary thyroid carcinoma patients before invasive procedures.
Ultrasound quarterly – Wolters Kluwer Health
Published: Jan 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.